Berberine pour Insulin Resistance
A Preuves Plusieurs grands essais cliniques montrent de manière constante des bénéfices significatifs.Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.
En conclusion
Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.
Key Study Findings
Population: Women with PCOS and insulin resistance
Population: None
Population: Obese population (herbal medicine review)
Population: Healthy individuals
Population: None
Population: HFD-induced NAFLD rat model
Key Statistics
27
Études
2500
Participants
Positive
Note
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Posologies couramment utilisées
- general:
- 500 mg 2-3x/day with meals
- starting:
- 500 mg/day and titrate
- metabolicsupport:
- 1,000-1,500 mg/day
Limite supérieure : 1,500 mg/day; GI side effects limit intake; potential drug interactions
Posologies étudiées dans la recherche
| Posologie | Durée | Effet | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| Various herbal medicines | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
Moment optimal de prise : With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)
Safety & Side Effects
Effets indésirables signalés
- ⚠ Diarrhea
- ⚠ Constipation
- ⚠ Flatulence
- ⚠ Abdominal pain
- ⚠ Potential hypoglycemia (when combined with diabetes medications)
Interactions connues
- ● Diabetes medications (may potentiate — hypoglycemia risk)
- ● CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
- ● CYP2D6 substrates
- ● Cyclosporine
- ● Metformin (additive effects)
Apport maximal tolérable : 1,500 mg/day; GI side effects limit intake; potential drug interactions
Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.
Frequently Asked Questions
Does Berberine help with Insulin Resistance?
How much Berberine should I take for Insulin Resistance?
Are there side effects of Berberine?
How strong is the evidence for Berberine and Insulin Resistance?
Related Evidence
Autres ingrédients pour Insulin Resistance
Berberine pour d'autres pathologies
References
- [1] Daniela Ciobârcă et al.. Pharmaceuticals (Basel). 2025. Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. doi:10.3390/ph18020279 PubMed
- [2] Lin Yin et al.. Front Nutr. 2025. The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in polycystic ovary syndrome. doi:10.3389/fnut.2025.1700612 PubMed
- [3] Qiao Zhang et al.. J Ethnopharmacol. 2023. Role of herbal medicine and gut microbiota in the prevention and treatment of obesity. doi:10.1016/j.jep.2022.116127 PubMed
- [4] Ayoub Amssayef et al.. Curr Pharm Des. 2023. Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review. doi:10.2174/0113816128270340231121043038 PubMed
- [5] Ting-Wei Zhu et al.. Clin Exp Pharmacol Physiol. 2023. Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome. doi:10.1111/1440-1681.13814 PubMed
- [6] Mingyue Zhong et al.. Food Funct. 2022. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. doi:10.1039/d2fo01009g PubMed
- [7] Shi-Jun Yue et al.. Am J Physiol Endocrinol Metab. 2019. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. doi:10.1152/ajpendo.00256.2018 PubMed
Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.